Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-29

FDA Approved: FYCOMPA — Original Application (Eisai Inc.)

View source ↗

Summary

The FDA granted original approval for FYCOMPA (perampanel) from Eisai Inc. for add-on therapy in patients with partial-onset seizures, marking the initial indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

ORIG AP for FYCOMPA (PERAMPANEL)